Eiken Chemical Co., Ltd. (TYO:4549)

Market Cap	95.74B +25.0%
Revenue (ttm)	41.28B +2.7%
Net Income	3.83B +76.0%
EPS	115.14 +85.8%
Shares Out	32.97M
PE Ratio	25.22
Forward PE	30.07
Dividend	58.00 (1.98%)
Ex-Dividend Date	Mar 30, 2026

Volume	171,900
Average Volume	209,155
Open	2,890.00
Previous Close	2,934.00
Day's Range	2,890.00 - 2,930.00
52-Week Range	1,972.00 - 3,345.00
Beta	0.34
RSI	51.37
Earnings Date	May 13, 2026

About Eiken Chemical

Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate s...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1939
• Employees: 702
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4549

Financial Performance

In fiscal year 2025, Eiken Chemical's revenue was 40.54 billion, an increase of 1.22% compared to the previous year's 40.05 billion. Earnings were 2.23 billion, a decrease of -15.41%.